A little pink pill called flibanserin got a green light last week from advisers to the FDA. Its purpose: to enhance sexual desire in women. The headline writers could not resist calling it “Viagra for women.” The same pill had been rejected twice before. At hearings it was called a “mediocre aphrodisiac with scary side effects.” But a big lobbying push demanded gender equity on the sex pill front – and finally got the panel’s recommendation. For “Viagra for women.” This hour On Point: the little pink pill. Women, sex, side-effects and the making of desire.
Interview:
https://onpoint.wbur.org/2015/06/08/hypoactive-sexual-desire-disorder-female-viagra
No comments:
Post a Comment